Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Breaks Above 200 Day Moving Average on Disappointing Earnings

Key Points

• Sabra shares climbed above their 200-day moving average, trading as high as $20.39, despite reporting quarterly EPS of $0.11—below the $0.16 consensus and down from $0.38 a year earlier.
• Revenue rose 31.4% year over year to $249.6 million, beating estimates, and Sabra raised its 2026 EPS guidance to $1.54–$1.55, above the previous analyst consensus.
• The REIT declared a quarterly dividend of $0.30 per share, or $1.20 annualized, with a reported yield of about 6%.

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) passed above its two hundred day moving average during trading on Tuesday following a stronger than expected earnings report. The stock has a two hundred day moving average of $19.97 and traded as high as $20.39. Sabra Healthcare REIT shares last traded at $20.35, with a volume of 4,574,479 shares.

The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.05). The business had revenue of $249.57 million for the quarter, compared to analyst estimates of $236.64 million. Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.56%. The company's revenue for the quarter was up 31.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.38 EPS.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, November 13th. Sabra Healthcare REIT's dividend payout ratio is 461.54%.

Key Stories Impacting Sabra Healthcare REIT

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Sabra raised its 2026 EPS guidance to $1.54–$1.55, above the prior analyst consensus of $1.52. Management also expects 7%–8% year-over-year earnings growth in 2026. Read More.
• Positive Sentiment: Third-quarter revenue rose 31.4% year over year to about $249.6 million, topping the roughly $236.6 million analyst estimate. A report also said quarterly FFO of $0.41 per share beat the $0.40 consensus. Read More.
• Positive Sentiment: Sabra is targeting 50% exposure to its senior housing operating portfolio (SHOP) by the end of 2027. Its CEO pointed to asset optimization and lease negotiations as additional sources of potential upside. Read More. · Read More.
• Positive Sentiment: The REIT declared a quarterly dividend of $0.30 per share, equivalent to $1.20 annually and a reported yield of 6%. Read More.
• Negative Sentiment: Reported third-quarter EPS was $0.11, below the $0.16 consensus and down from $0.38 a year earlier. This earnings shortfall tempers the stronger revenue and outlook news. Read More.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on SBRA. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an "underperform" rating to a "market perform" rating in a research report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Wells Fargo & Company cut their target price on Sabra Healthcare REIT from $23.00 to $21.00 and set an "overweight" rating for the company in a research note on Monday, October 19th. Weiss Ratings downgraded Sabra Healthcare REIT from a "hold (c+)" rating to a "hold (c)" rating in a report on Thursday, October 8th. Finally, Citigroup reiterated a "market outperform" rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Seven research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, Sabra Healthcare REIT presently has an average rating of "Moderate Buy" and an average price target of $21.50.

Insiders Place Their Bets

In other news, CEO Richard Matros sold 200,000 shares of the business's stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the transaction, the chief executive officer owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. The trade was a 10.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.09% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Pictet Asset Management Holding SA lifted its position in Sabra Healthcare REIT by 6.3% in the 3rd quarter. Pictet Asset Management Holding SA now owns 41,937 shares of the real estate investment trust's stock valued at $827,000 after acquiring an additional 2,467 shares in the last quarter. Heritage Family Offices LLP bought a new stake in Sabra Healthcare REIT during the 3rd quarter worth approximately $45,000. Kestra Advisory Services LLC increased its holdings in Sabra Healthcare REIT by 12.2% during the 3rd quarter. Kestra Advisory Services LLC now owns 178,538 shares of the real estate investment trust's stock worth $3,521,000 after purchasing an additional 19,344 shares in the last quarter. Oregon Public Employees Retirement Fund raised its stake in shares of Sabra Healthcare REIT by 1.5% in the third quarter. Oregon Public Employees Retirement Fund now owns 52,885 shares of the real estate investment trust's stock worth $1,043,000 after purchasing an additional 800 shares during the last quarter. Finally, Asset Management One Co. Ltd. raised its stake in shares of Sabra Healthcare REIT by 0.8% in the third quarter. Asset Management One Co. Ltd. now owns 475,624 shares of the real estate investment trust's stock worth $9,379,000 after purchasing an additional 3,859 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Healthcare REIT Stock Up 3.2%

The company has a market cap of $5.20 billion, a P/E ratio of 72.68, a price-to-earnings-growth ratio of 1.79 and a beta of 0.68. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07. The stock has a fifty day moving average price of $19.85 and a two-hundred day moving average price of $19.97.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.